- Home
- ENTO vs WHLR Comparison
ENTO vs WHLR Comparison
Compare ENTO & WHLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTO
- WHLR
- Stock Information
- Founded
- ENTO 2014
- WHLR 2011
- Country
- ENTO United States
- WHLR United States
- Employees
- ENTO 2
- WHLR N/A
- Industry
- ENTO Biotechnology: Pharmaceutical Preparations
- WHLR Real Estate Investment Trusts
- Sector
- ENTO Health Care
- WHLR Real Estate
- Exchange
- ENTO Nasdaq
- WHLR Nasdaq
- Market Cap
- ENTO 1.7M
- WHLR 1.5M
- IPO Year
- ENTO 2016
- WHLR 2012
- Fundamental
- Price
- ENTO $0.36
- WHLR $1.20
- Analyst Decision
- ENTO
- WHLR
- Analyst Count
- ENTO 0
- WHLR 0
- Target Price
- ENTO N/A
- WHLR N/A
- AVG Volume (30 Days)
- ENTO 1.4M
- WHLR 2.9M
- Earning Date
- ENTO 05-20-2025
- WHLR 05-05-2025
- Dividend Yield
- ENTO N/A
- WHLR N/A
- EPS Growth
- ENTO N/A
- WHLR N/A
- EPS
- ENTO N/A
- WHLR N/A
- Revenue
- ENTO N/A
- WHLR $104,307,000.00
- Revenue This Year
- ENTO N/A
- WHLR N/A
- Revenue Next Year
- ENTO N/A
- WHLR N/A
- P/E Ratio
- ENTO N/A
- WHLR N/A
- Revenue Growth
- ENTO N/A
- WHLR 2.26
- 52 Week Low
- ENTO $0.19
- WHLR $1.09
- 52 Week High
- ENTO $3.24
- WHLR $15,192.00
- Technical
- Relative Strength Index (RSI)
- ENTO 38.33
- WHLR 16.99
- Support Level
- ENTO $0.38
- WHLR $1.09
- Resistance Level
- ENTO $0.39
- WHLR $1.40
- Average True Range (ATR)
- ENTO 0.04
- WHLR 0.38
- MACD
- ENTO -0.00
- WHLR 0.50
- Stochastic Oscillator
- ENTO 18.24
- WHLR 4.18
About ENTO Entero Therapeutics Inc. Common Stock
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.